Skip to main content
. Author manuscript; available in PMC: 2014 Jul 16.
Published in final edited form as: Drug Metab Rev. 2013 Sep 24;46(1):72–85. doi: 10.3109/03602532.2013.839700

Figure 1.

Figure 1

Representations of SCB-laced herbal incense commonly called K2 (A), typical packaging of K2 and similar products (B), and labeling of K2 packages that explicitly states “not for consumption” (C). Figures (A) and (B) are courtesy of the DEA. Figure (C) is courtesy of the Arkansas Department of Health, Public Health Laboratory.

HHS Vulnerability Disclosure